Monday, January 23, 2006

Update: FDA Considers an OTC Version of the Fat-blocker Xenical

The FDA advisory committee voted 11 to 3 today to recommend the OTC version of orlistat* for final FDA approval.

The FDA usually follows the recommendation of its advisory committees. Full FDA approval could be months away.

* If you have diabetes, its advisable to consult with your doctor before taking non-prescription orlistat (Alli). Its use may necessitate changes to diabetes medications.


GlaxoSmithKline's Press Release:
FDA Joint Advisory Committee Recommends Approval of Orlistat 60 MG Capsules for Over-the-counter Use

News summaries:
Diet Pill Gets Closer to Store Shelves
FDA Panel Recommends OTC Weight-Loss Pill